Molecule Pharma Limited


Director	Pranav Pradipkumar Shah


Registered Address	231 Kenton Road
	Harrow
	HA3 0HD


Registered Number	14284456 (England and Wales)

Statement of Financial Position
31 August 2025

	Notes	2025		2024
		£	£	£	£
Fixed assets
Intangible assets	3		1,474,188		1,435,500
			1,474,188		1,435,500
Current assets
Debtors	4	1,468		104,212
Cash at bank and on hand		104,318		188,742
		105,786		292,954
Creditors amounts falling due within one year	5	(217,977)		(98,098)
Net current assets (liabilities)			(112,191)		194,856
Total assets less current liabilities			1,361,997		1,630,356
Creditors amounts falling due after one year	6		(1,813,760)		(1,655,147)
Net assets			(451,763)		(24,791)
Capital and reserves
Called up share capital			81,163		81,000
Profit and loss account			(532,926)		(105,791)
Shareholders' funds			(451,763)		(24,791)

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 31 August 2026, and are signed on its behalf by:

Pranav Pradipkumar Shah
Director
Registered Company No. 14284456

Molecule Pharma Limited

Notes to the Financial Statements
for the year ended 31 August 2025

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Going concern
	The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.

Going concern

The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.

	Turnover policy
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

	Foreign currency translation
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

Foreign currency translation

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

	Intangible assets
	Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.

2.	Average number of employees


		2025		2024
	Average number of employees during the year	1		2

3.	Intangible assets

	Other	Total
	£	£
Cost or valuation
At 01 September 24	1,650,000	1,650,000
Additions	150,000	150,000
At 31 August 25	1,800,000	1,800,000
Amortisation and impairment
At 01 September 24	214,500	214,500
Charge for year	111,312	111,312
At 31 August 25	325,812	325,812
Net book value
At 31 August 25	1,474,188	1,474,188
At 31 August 24	1,435,500	1,435,500

4.	Debtors: amounts due within one year

	2025	2024
	£	£
Trade debtors / trade receivables	-	93,990
Other debtors	1,000	1,000
Prepayments and accrued income	468	9,222
Total	1,468	104,212

5.	Creditors: amounts due within one year

	2025	2024
	£	£
Trade creditors / trade payables	200,731	3,720
Taxation and social security	14,951	92,628
Accrued liabilities and deferred income	2,295	1,750
Total	217,977	98,098

6.	Creditors: amounts due after one year

	2025	2024
	£	£
Other creditors	1,813,760	1,655,147
Total	1,813,760	1,655,147